NCT03838770View on ClinicalTrials.gov

tDCS for the Management of Multiple Sclerosis Related Fatigue

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Multiple Sclerosis
Interventions
DEVICE

Active tDCS

Active target 2.0mA tDCS (n=60)

DEVICE

sham tDCS

sham left-anodal dorsolateral prefrontal cortex (DLFPC) montage

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

lead

NYU Langone Health

OTHER

NCT03838770 - tDCS for the Management of Multiple Sclerosis Related Fatigue | Biotech Hunter | Biotech Hunter